Clinical Trial

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-19; most recent amendment 2026-07-13.
Status change: Recruiting → Active, Not Recruiting 2026-07-13
Trial Details
NCT Number NCT07041125
Lead Sponsor Heart Rhythm Clinical and Research Solutions, LLC
Collaborators: Boston Scientific Corporation
Conditions PFA Ablation and LAAC Procedures
Enrollment 120 participants
Start Date 2025-06-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-15